AstraZeneca (AZN)

Add to Watchlists
Create an Alert
63.49 -0.04  -0.06% NYSE Apr 17, 8:00PM BATS Real time Currency in USD

AstraZeneca Cash from Financing (TTM):

-3.047B for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

AstraZeneca Cash from Financing (TTM) Chart

Export Data
Save Image

AstraZeneca Historical Cash from Financing (TTM) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 -3.047B
Sept. 30, 2013 -3.773B
June 30, 2013 -2.903B
March 31, 2013 -3.717B
Dec. 31, 2012 -4.923B
Sept. 30, 2012 -6.079B
June 30, 2012 -8.687B
March 31, 2012 -8.952B
Dec. 31, 2011 -9.321B
Sept. 30, 2011 -9.46B
June 30, 2011 -8.341B
March 31, 2011 -7.803B
Dec. 31, 2010 -7.334B
Sept. 30, 2010 -5.45B
June 30, 2010 -5.189B
March 31, 2010 -4.713B
Dec. 31, 2009 -3.629B
Sept. 30, 2009 -5.193B
June 30, 2009 -6.031B
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Financing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More

Get data for
Advertisement

AZN Cash from Financing (TTM) Benchmarks

Companies
GlaxoSmithKline -10.34B
Pfizer -14.98B
Johnson & Johnson -6.091B

AZN Cash from Financing (TTM) Range, Past 5 Years

Minimum -9.46B Sep 2011
Maximum -2.903B Jun 2013
Average -6.029B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.